for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Almirall Announces FDA Approval Of Updated Label For Seysara Tablets

June 18 (Reuters) - Almirall SA:

* ALMIRALL ANNOUNCES FDA APPROVAL OF UPDATED LABEL FOR SEYSARA® (SARECYCLINE) TABLETS

* ALMIRALL - SEYSARA LABEL UPDATE STATES THAT PROPIONIBACTERIUM ACNES STRAINS DISPLAYED A LOW PROPENSITY FOR DEVELOPMENT OF RESISTANCE TO SARECYCLINE Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up